Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland.
Baillie K, Mueller T, Pan J, Laskey J, Bennie M, Crearie C, Kavanagh K, Alvarez-Madrazo S, Morrison D, Clarke J, Keel A, Cameron D, Wu O, Kurdi A, Jones RJ.
Baillie K, et al. Among authors: kurdi a.
Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):653-663. doi: 10.1002/pds.4998. Epub 2020 Apr 21.
Pharmacoepidemiol Drug Saf. 2020.
PMID: 32316077
Free PMC article.